THSTI: Taking Lab Research to Patients

A lab discovery and a patient’s treatment can be many years apart. A new idea must be tested, made in bulk, checked by regulators and tried on people. Many good ideas stall on this road.

Think of a bridge. On one bank stands a lab with a promising result. On the other bank stands a patient who needs it. THSTI tries to build the bridge between them.

1.1 What is THSTI, and where is it?

THSTI is the Translational Health Science and Technology Institute. It is an institute under the Department of Biotechnology (DBT). It sits at the NCR Biotech Science Cluster in Faridabad, Haryana.

The Union Cabinet approved it on 6 September 2008. It was registered as a society on 15 July 2009 under the Societies Registration Act, 1860. Its Foundation Day is on the same date, 15 July. The 17th Foundation Day fell on 15 July 2026.

What does “translational” mean? It means turning a research finding into something people can use. That could be a vaccine, a test or a new treatment.

Common mistake: THSTI is not a hospital or a medical college. It is a research institute. It has a clinical research centre, but its main job is to move research towards products.

1.2 Who runs it today?

THSTI is now an institute of the Biotechnology Research and Innovation Council (BRIC). BRIC is an autonomous body of DBT. DBT is part of the Ministry of Science and Technology.

The 2026 Foundation Day was addressed by Dr Rajesh Gokhale, who is DBT Secretary and BRIC Director General. The 2026 industry meet named Prof. Ganesan Karthikeyan as Executive Director.

Before BRIC, each DBT institute worked as its own separate body. The government then joined them under one roof.

2.1 What is BRIC?

In 2024, PIB said DBT had subsumed its 13 autonomous institutions into one autonomous body, BRIC. BRIC is registered as a society.

Why join them? One body can plan research, share money and link labs and industry more easily. Separate small bodies find this harder.

How do you read “subsumed”? It means the older institutes became part of the new body. They did not close. THSTI still works under its own name.

Common mistake: some sources say 14 institutes. This lesson follows the PIB release, which says 13. If an exam gives a number, check what the question’s source says.

THSTI’s research covers a wide range of health problems. Its website lists nine thematic areas.

3.1 Which research areas does it list?

• Maternal and child health
• Virus research, therapeutics and vaccines
• Tuberculosis research
• Microbial research
• Immunobiology and immunotherapy
• Drug discovery
• Clinical development services
• Computational and mathematical biology
• Bio-design and diagnostics

Why so many areas? Translation needs many skills together. A vaccine needs virus experts, clinical staff, data experts and engineers.

Common mistake: do not say THSTI has “six centres”. Its own site lists nine thematic areas.

3.2 What has it produced for mothers and babies?

• GARBH-INi-DRISHTI: a repository of data and samples from over 12,000 pregnant women, their newborns and mothers.
• Technology transfer: a Lactobacillus crispatus consortium was transferred to the company Sundyota Numandis in February 2025.
• Ferret Research Facility: India’s first, dedicated at THSTI in February 2025.

What is a ferret facility for? PIB says it works to high biosafety and research standards. It supports research on infectious and non-communicable diseases.

Research is only half the road. The other half is testing on people.

4.1 What does the Medical Research Centre do?

On 22 February 2023, facilities worth Rs 120 crore were inaugurated at THSTI. They included a Medical Research Centre (MRC), planned as a 50-bed hospital for clinical research.

By July 2026, PIB said the MRC was fully operationalised. It has three notable parts.

• An early-phase clinical trial unit
• A CAR-T cell unit
• India’s first Controlled Human Infection Studies (CHIS) facility

What is a CHIS? Healthy volunteers are exposed to a germ in a safe, tightly watched setting. Doctors can then see how a vaccine or drug works faster.

Common mistake: a CHIS facility is not a general hospital ward. It is a research set-up for planned studies.

THSTI also tries to link labs with companies. SYNCHN is one way.

5.1 What is SYNCHN?

SYNCHN is THSTI’s annual industry meet.

• 2024: the first meet, on 14 July 2024. It produced 13 Letters of Intent.
• 2025: the second meet. It produced 19 binding strategic agreements.
• 2026: the third meet, held on 15 July 2026, with the theme “Synergistic Collaboration in Healthcare Innovation”.

What is the difference? A Letter of Intent says the parties plan to work together. A binding agreement is a firm commitment.

5.2 What is APEX?

APEX stands for Accelerated Productisation and Epidemic Preparedness. It is a national-scale pilot production platform. It aims to close the gap between a proven research result and a product that can be made.

Why is this gap hard? A result that works in a small lab may fail when made in large amounts. A pilot platform tests that step.

6.1 What were the Foundation Day and SYNCHN 2026 events?

On 15 July 2026, THSTI held its 17th Foundation Day. Prof. Roger Foo of the National University of Singapore gave the Foundation Day lecture. He spoke about moving from treating disease after it appears to preventing it early.

He praised THSTI’s 17-year journey.

The same day, THSTI hosted SYNCHN 2026. Dr Kiran Mazumdar-Shaw of Biocon was Chief Guest and spoke virtually. Speakers also came from CDSCO, NITI Aayog and BIRAC. IVCA said India’s bioeconomy is growing about 18% year-on-year.

Memory hook: Cabinet 2008, society 2009, 2024 first SYNCHN, 2026 third SYNCHN and 17th Foundation Day.